Aileron Therapeutics, Inc. (ALRN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 52.16M |
| Enterprise Value | 48.95M |
| P/E Ratio | -0.34 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.86 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.16 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.75 |
| Return On Equity | -2.34 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 1,000 |
| Net Income | -49.87M |
| Diluted EPS | -1.96 |
Balance Sheet
| Total Cash | 40.65M |
| Total Cash/Share | 1.34 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.27 |
| Book Value Per Share | 0.34 |
Price History
| 52-Week Change | -56.04 |
| 52-Week High | 7.42 |
| 52-Week Low | 1.61 |
| Moving Average 50 Days | 2.37 |
| Moving Average 200 Days | 3.04 |
Statistics
| Average Volume | 101,120 |
| Shares Outstanding | 21.67M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | November 11, 2022 |
AD
